Letters and urgent communications 2020
Topics:
Date published:
Last updated:
Advice from the Chief Medical Officer to HSC professionals for 2020
Documents
- HSS (MD) 94/2020 – From the Chief Medical Officer Dr Michael McBride, regarding the UK COVID-19 Vaccination Programmes
- HSS (MD) 93/2020 - Deployment of the Astrazeneca Covid-19 Vaccine in Northern Ireland and Updated Jcvi Advice on Covid-19 Vaccines
- HSS (MD) 92/2020 - New Variant of SARS-CoV-2 Virus in South Africa : Action for Health Service in Northern Ireland
- HSS (MD) 91/2020 - COVID-19 Therapeutic Alert - Therapeutic Anticoagulation (Heparin) in the Management of Severe COVID-19 (SARS-CoV-2) Positive Patients
- HSS (MD) 90/2020 - Guidance on death certification during the Covid-19 pandemic
- HSS (MD) 89/2020 - Hysteroscopy: Pain management and informed consent
- HSS (MD) 88/2020 - The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020
- HSS (MD) 87/2020 - Updated Resuscitation Council UK Guidance on the Management of Anaphylaxis in the Vaccination Setting
- HSS(MD) 86/2020 - Covid-19 therapeutic alert - Azithromycin in the management of Covid-19 (Sars-CoV-2) positive patients
- HSS (MD) 85/2020 - Adrenaline for anaphylaxis kits – A reminder to healthcare professionals
- HSS (MD) 84/2020 - Pfizer BioNtech Covid-Vaccine - Updated guidance on managing allergic reactions
- HSS(MD) 83/2020 - Continuation of Seasonal Flu Programme by Peer Vaccinators
- HSS (MD) 82/2020 - Deployment of the Covid-19 Vaccine in Northern Ireland
- HSS (MD) 81/2020 - Atracurium Besilate Solution for Injection Vials and Ampoules (All Strengths) – Supply Disruption Alert
- HSS (MD) 80/2020 – Winter Vaccines and Research
- HSS (MD) 79/2020 - Confirmed Influenza isolates in Northern Ireland - NICE guidance on use of antivirals now applies
- HSS (MD) 78/2020 - Publication of an Interim Position Statement : Tocilizumab for Patients admitted to ICU with COVID-19 Pneumonia (Adults)
- Interim Position Statement: Tocilizumab for patients admitted to ICU with COVID-19 pneumonia (adults) - 25 November 2020
- HSS (MD) 77/2020 - Expression of Interest to all Registered Health Care Professionals to Become Sessional Vaccinators to Help Implement the Forthcoming COVID-19 Vaccination Programme
- HSS (MD) 76/2020 - Supporting Doctors throughout the Second COVID-19 Wave
- HSS (MD) 75/2020 - Publication of a Revised Interim Clinical Commissioning Policy - Remdesivir for Patients Hospitalised with COVID-19 (Adults and Children aged 12 Years and over
- Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19 (adults and children 12 years and older) Version 2
- HSS(MD) 74 2020 - Immediate Actions in response to Mink-Variant Sars-Cov-2 virus in Denmark
- HSS (MD) 73/2020 - Interim Policy to Extend the Provision of Passive Immunisation against Respiratory Syncytial Virus for at Risk Preterm Infants
- HSS (MD) 72/2020 - The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020: Amendments to the Human Medicines Regulations 2012
- HSS (MD) 71/2020 - Lithium Carbonate (Priadel®) 200mg And 400mg Modified Release Tablets – Updated Supply Disruption Alert
- HSS (MD) 70/2020 - COVID-19 - 'Shielding' Guidance for Children and Young People: Royal College of Paediatrics And Child Health (RCPCH)
- HSS (MD) 69/2020 - Remdesivir for patients hospitalised with Covid-19 - Supply disruption alert
- HSS (MD) 68/2020 - Letter to all Health and Social Care workers encouraging everyone to obtain the flu vaccine
- HSS (MD) 67/2020 - Minimising the risk of COVID-19 outbreaks in healthcare settings.
- HSS(MD) 66/2020 - Management of seasonal flu
- HSS (MD) 65/2020 - COVID-19 - Therapeutic alert update : Remdesivir for patients hospitalised with Covid-19 (Adults abd children aged 12 years and older)
- HSS (MD) 64/2020 – COVID-19 Therapeutic Alert Update: Corticosteroids in the Treatment of Suspected or Confirmed COVID-19
- HSS (MD) 63/2020 - National Patient Safety Alert - Steroid Emergency Card to Support Early Recognition and Treatment of Adrenal Crisis in Adults
- HSS (MD) 62/2020 - Lithium Carbonate (Priadel®) 200mg and 400mg Modified Release Tablets – Supply Disruption Alert
- HSS (MD) 61/2020 - FOR ACTION: Healthcare Safety Investigation Branch National Learning Report - Severe Brain Injury, Early Neonatal Death and Intrapartum Stillbirth associated with Group B Streptococcus Infection - July 2020
- HSS (MD) 60/2020 - COVID 19 Research letter
- HSS (MD) 59/2020 - Seasonal Influenza Vaccination Programme 2020/21
- HSS (MD) 59/2020 (Addendum) - Seasonal Influenza Vaccination Programme
- HSS (MD) 58/2020 - Use of Face Masks/Face Covering in all Health and Social Care Facilities - Updated as of 11 August 2020
- HSS (MD) 57/2020 - Emollients - New information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
- HSS (MD) 56/2020 - National Patient Safety Alert - Risk of Death from Unintended Administration of Sodium Nitrite
- HSS (MD) 55/2020 - Shingles Vaccination Programme Eligibility Criteria for 2020/21
- HSS (MD) 54/2020 - Personal Protective Equipment and Heat - Risk of Heat Stress
- HSS (MD) 53/2020 - Evidence of Harm from Illicit or Fake Benzodiazepines
- HSS (MD) 52/2020 - Cannabis Oil Disguised as Confectionary
- HSS (MD) 51/2020 - Cannabis-based medicinal products - Update
- HSS (MD) 50/2020 - Early Access to Medicines Scheme (EAMS)
- HSS (MD) 49/2020 - COVID-19 Therapeutic Alert Update : Remdesivir for Patients Hospitalised with COVID-19 (Adults and Children aged 12 Years and older
- HSS (MD) 48/2020 - Phenelzine Sulphate 15mg Tablets (Nardil®) – Supply Disruption
- HSS (MD) 47/2020 - Dexamethasone in Covid-19
- HSS (MD) 46/2020 - Re-Scheduling Of Epidyolex (Cannabis Based Medicine) and Insertion of a New Definition under the Misuse Of Drugs Regulations (NI) 2002
- HSS (MD) 45/2020 - Cardiopulmonary Resuscitation (CPR), As An Aerosol Generating Procedure (AGP)
- HSS (MD) 44/2020 - Regional Ethics Advice and Support Framework
- COVID-19 - Guidance Ethical Advice and Support Framework
- COVID-19 Guidance - Ethical Advice and Support Framework - Plain English
- COVID-19 Guidance - Ethical Advice and Support Framework - Easy Read
- HSS (MD) 43/2020 - Covid-19 Therapeutic alert further update: Early access to medicines scheme for Rendesivir in the treatment of Covid-19
- HSS (MD) 42/2020 - SARS-CoV2 Antibody Testing - Programme Rollout
- HSS (MD) 41/2020 - COVID-19 Therapeutic Alert Update: Early access to medicines scheme for Remdesivir in the treatment of COVID-19 - Implementation of the scheme and management of supply in Northern Ireland
- HSS (MD) 40/2020 - Danazol 100mg and 200mg Capsules – Supply Disruption Alert
- HSS (MD) 39/2020 - Zyban® (Bupropion Hydrochloride) 150mg Prolonged Release Tablets - Supply Disruption Alert
- HSS (MD) 38/2020 - COVID-19 Contact Tracing Strategy And Programme in Northern Ireland - ‘Test, Trace And Protect’
- HSS (MD) 37/2020 - COVID-19 Therapeutic Alert: Early Access to Medicines Scheme for Remdesivir in the Treatment of Covid-19 – Implementation of the Scheme and Management of Supply in Northern Ireland
- HSS (MD) 36/2020 - Neuromuscular Blocking Agents: Atracurium, Cisatracurium and Rocuronium – Updated Supply Disruption Alert
- HSS (MD) 35/2020 - COVID-19 Case Definition Change
- HSS (MD) 34/2020 - Salazopyrin® (Sulfasalazine) 500mg Suppositories – Supply Disruption Alert
- HSS (MD) 33/2020 - Phosphate Polyfusor 500ml - Supply Disruption Alert
- HSS (MD) 32/2020 - Yellow Card Reporting Site for Healthcare Products Used in Coronavirus (COVID-19)
- HSS (MD) 31/2020 – Valproate Pregnancy Prevention Programme : Temporary Advice for Management during Covid-19 Pandemic
- HSS (MD) 30/2020 - Multisystem Inflammatory Syndrome in Children Temporally Associated with Covid-19
- HSS (MD) 29/2020 - Ativan® (Lorazepam) 4mgml Solution for Injection – Supply Disruption
- CMO letter to Professor Greer, Queen's University Belfast - 24 April 2020
- HSS (MD) 28/2020 - Guidance on Death Certification during the COVID-19 Pandemic
- HSS (MD) 27/2020 - Renal Replacement Therapy in Critical Care Severe Disruption to the supply of kits and fluids to perform continuous vein to vein haemofiltration including haemodiafiltration (CVVH and CVVHD)
- HSS (MD) 26/2020 - COVID-19 - PPE Guidance Update
- HSS (MD) 25/2020 - Neuromuscular Blocking Agents Atacurium, Cisatracurium and rocuronium - supply disruption alert
- HSS (MD) 24/2020 - Continuation of Immunisation Programmes During COVID-19 Pandemic
- HSS (MD) 23/2020 - COVID-19 – Message to all Clinical Staff – Ibuprofen and Coronavirus (Covid-19)
- HSS (MD) 22/2020 - End of the 2019 2020 Flu Season and Related Issues
- HSS (MD) 21/2020 - COVID 19 - Optimising Use of Critical Care Medicines
- HSS (MD) 20/2020 - COVID-19 - PPE Guidance Update
- HSS (MD) 19/2020 - Personal Protective Equipment (PPE) – Update to Service
- HSS (MD) 18/2020 - Guidance on the New Arrangements for the Completion and Issuing of Medical Certificates of Cause of Death and Stillbirth Certificates
- HSS (MD) 17/2020 - COVID-19 - Chloroquine and Hydroxychloroquine not licensed for COVID-19 treatment
- HSS (MD) 16/2020 - Diamorphine Hydrochloride Powder for reconstitution and injection 5mg and 10mg ampoules - updated supply disruption alert
- HSS (MD) 15/2020 - Novel Coronavirus - Anti-Inflammatory Medications
- HSS (MD) 14/2020 16 March 2020 - Novel Coronavirus: Advice for HSC in Northern Ireland
- HSS(MD) 11 2020 - Epanutin (Phenytoin) 30mg-5ml Oral Suspension - Supply Disruption Alert
- HSS (MD) 13-2020 - COVID-19 Maintaining the supply of medicines to patients
- HSS(MD) 12/2020 - Message for Clinical Staff Encountering Patients with Respiratory Infections Arrived from Overseas
- HSS(MD) 10/2020 - Diamorphine Hydrochloride Powder for Reconstitution and Injection 5mg and 10mg Ampoules – Supply and Distribution
- HSS(MD) 9/2020 - Covid-19 Becomes a Notifiable Disease in Northern Ireland
- HSS (MD) 8/2020 25 February 2020 - Updated Advice In Relation to the Novel Coronavirus (Covid-19) - Includes Flowcharts
- HSS (MD) 07/2020 07 February 2020 - Updated Advice in Relation to the Novel Coronavirus (2019-nCoV) - Includes Contacts and Flowcharts
- HSS (MD) 06/2020 04 February 2020 - Cannabis Based Products for Medicinal Use – Update
- HSS (MD) 05/2020 31 January 2020 - Updated Advice - Novel Coronavirus (2019-nCoV) - Includes Pathway
- HSS (MD) 04/2020 24 January 2020 - Wuhan Novel Coronavirus - Message for all Clinical Staff Encountering Patients with Respiratory Infections Arrived from Overseas
- HSS (MD) 03/2020 24 January 2020 - Change to the Infant Pneumococcal Conjugate Vaccine (PCV13) Schedule
- HSS (MD) 02/2020 22 January 2020 - Publication of a New Regional Policy for the Administration of Intravenous Fluids to Children Aged from Birth (Term) until their 16th Birthday: Reducing the Risk of Harm due to Hyponatraemia and Competency Framework
- HSS (MD) 01/2020 15 January 2020 - Phenytoin Sodium NRIM 100MG Capsules (ACCORD) – Supply Disruption Alert